Editor
Neil Love, MD
Associate
Editors
Michelle Finkelstein, MD
Richard Kaderman, PhD
Writers
Jennifer Motley, MD
Sally Bogert, RNC, WHCNP
Print
Design
John Westmark
Web
Design
John Ribeiro
Copy
Editor
Pat Morrissey/Havlin
Audio
Production
Frank Cesarano
|
Technical
Services
Arly Ledezma
Production
Coordinator
Cheryl Dominguez
Editorial
Assistant
Patricia McWhorter
Contact
Information
Neil Love, MD
Director, Physician and Community Education
University of Miami Conference Center
400 SE Second Avenue, Suite 401
Miami, Florida 33131-2117
Fax: (305)
377-9998
Email: nlove@med.miami.edu
|
Pharmaceutical agents discussed in this
program |
Generic |
Trade |
Manufacturer |
anastrozole |
Arimidex ® |
AstraZeneca Pharmaceuticals, LP |
capecitabine |
Xeloda ® |
Roche |
docetaxel |
Taxotere ® |
Aventis Pharmaceuticals |
doxorubicin hydrochloride |
Adriamycin ® |
Pharmacia Corporation |
exemestane phosphate |
Aromasin ® |
Pharmacia Corporation |
gemcit abine HCL |
Gemzar ® |
Eli Lilly & Co. |
letrozole |
Femara ® |
Novartis Pharmaceuticals |
leuprolide acetate |
Lupron ® |
TAP Pharmaceuticals, Inc. |
megestrol acetate |
Megace ® |
Bristol-Myers Squibb Company |
paclitaxel |
Taxol ® |
Bristol-Myers Squibb Company |
tamoxifen citrate |
Nolvadex ® |
AstraZeneca Pharmaceuticals, LP |
toremifene citrate |
Fareston ® |
Shire Laboratories, Inc. |
trastuzumab |
Herceptin ® |
Genentech, Inc. |
vinorelbine tartrate |
Navelbine ® |
Glaxo Wellcome, Inc. |
©
NL Communications, Inc. 2001. All rights reserved. This program
was supported by an unrestricted educational grant from AstraZeneca
Pharmaceuticals LP. The audio tapes, compact discs, Internet
content and accompanying printed material is protected by
copyright. No part of this program may be reproduced or transmitted
in any form or by any means, electronic or mechanical, including
photocopying, recording, or utilizing any information storage
and retrieval system, without written permission from the
copyright owner. The opinions expressed are those of the presenters
and are not to be construed as those of the publisher or grantor.
As part of this program, materials and presentations may include
information regarding the use of drugs that may be inconsistent
with or outside the approved labeling of these products. Healthcare
professionals should note that the use of these agents outside
current approved labeling is considered experimental and are
advised to consult prescribing information for these products.
Please refer to the U.S. product information for complete
information about each drug.
|